ADMA

14.56

3.51% -0.53

Dopo l'orario di chiusura: 14.58 0.02 +0.14%

Adma Biologics Inc (ADMA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$15.09

Aprire:

$15.1

Volume 24 ore:

2.41M

Relative Volume:

0.74

Capitalizzazione di mercato:

$3.47B

Reddito:

$474.17M

Utile/perdita netta:

$208.93M

Rapporto P/E:

17.14

EPS:

0.8493

Flusso di cassa netto:

$65.61M

1 W Prestazione:

-1.22%

1M Prestazione:

-7.20%

6M Prestazione:

-31.42%

1 anno Prestazione:

-11.44%

Intervallo 1D:

$14.47

$15.18

Intervallo di 1 settimana:

$14.28

$15.60

Portata 52W:

$13.82

$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Nome

Adma Biologics Inc

Settore

Healthcare (1140)

Industria

Biotechnology (637)

Telefono

(201) 478-5552

Indirizzo

C/O ADMA BIOLOGICS, INC., RAMSEY

Dipendente

685

Cinguettio

@AdmaBiologics

Prossima data di guadagno

2025-03-03

Ultimi documenti SEC

ADMA's Discussions on Twitter

Confronta ADMA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADMA Adma Biologics Inc	14.56	3.57B	474.17M	208.93M	65.61M	0.8493
VRTX Vertex Pharmaceuticals Inc	408.61	105.69B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.07	61.52B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	569.17	60.69B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	837.28	50.05B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	318.02	35.25B	4.56B	-176.77M	225.30M	-1.7177

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-07-19	Ripresa	Raymond James	Strong Buy
2022-10-13	Iniziato	Mizuho	Buy
2021-11-11	Aggiornamento	Raymond James	Outperform → Strong Buy
2021-11-09	Iniziato	Cantor Fitzgerald	Overweight
2019-06-04	Iniziato	Jefferies	Buy
2019-04-15	Reiterato	H.C. Wainwright	Buy
2019-02-07	Ripresa	H.C. Wainwright	Buy
2017-12-11	Reiterato	Maxim Group	Buy
2017-11-14	Aggiornamento	Raymond James	Mkt Perform → Outperform
2017-01-23	Aggiornamento	Maxim Group	Hold → Buy
2016-08-01	Downgrade	Maxim Group	Buy → Hold
2016-07-25	Reiterato	Maxim Group	Buy
2015-05-13	Reiterato	Maxim Group	Buy
2014-12-08	Iniziato	Oppenheimer	Outperform
2014-12-01	Reiterato	Maxim Group	Buy

Mostra tutto

Adma Biologics Inc Borsa (ADMA) Ultime notizie

Oct 16, 2025

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - sharewise.com

Oct 16, 2025

How to build a dashboard for ADMA Biologics Inc. stockCEO Change & Long-Term Capital Growth Strategies - newser.com

Oct 16, 2025

Applying Wyckoff theory to ADMA Biologics Inc. stockGlobal Markets & Daily Technical Forecast Reports - newser.com

Oct 16, 2025

Oct 15, 2025

3 Biotech Stocks I Am Accumulating - Seeking Alpha

Oct 15, 2025

What momentum shifts mean for ADMA Biologics Inc.July 2025 Retail & Advanced Technical Signal Analysis - newser.com

Oct 15, 2025

Can ADMA Biologics Inc. stock attract ESG capital inflowsWeekly Profit Analysis & Fast Entry Momentum Alerts - newser.com

Oct 15, 2025

Sentiment analysis tools applied to ADMA Biologics Inc.Share Buyback & Low Drawdown Momentum Ideas - newser.com

Oct 15, 2025

Will ADMA Biologics Inc. rebound enough to break evenJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com

Oct 15, 2025

Can ADMA Biologics Inc. stock beat market expectations this quarterEntry Point & Low Risk High Win Rate Picks - newser.com

Oct 15, 2025

Comparing ADMA Biologics Inc. in custom built stock radarsEarnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com

Oct 15, 2025

Oct 14, 2025

Can momentum traders help lift ADMA Biologics Inc.July 2025 Market Mood & Low Drawdown Investment Strategies - newser.com

Oct 14, 2025

How Analyst Upgrades and Rising EPS Expectations at ADMA Biologics (ADMA) Have Changed Its Investment Story - Sahm

Oct 14, 2025

Volume spikes in ADMA Biologics Inc. stock – what they meanWeekly Loss Report & Accurate Technical Buy Alerts - newser.com

Oct 14, 2025

Oct 13, 2025

Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - sharewise.com

Oct 13, 2025

ADMA Biologics (NASDAQ:ADMA) Shareholder Returns Have Been Massive, Earning 549% in 5 Years - 富途牛牛

Oct 13, 2025